Literature DB >> 33688327

Non-alcoholic fatty liver disease and associated risk factors in health care professionals in a community hospital in Brazil.

Vitória Dos Santos Magalhães1, Thais Dall Acqua Jost1, Henrique Mezzomo Pasqual1, Anna Lourdes Gueller Becker1, Luiza Maidana Marques1, Mônica Manica1, Bernardo Luis Lazzaroto Delani1, João Pedro Langaro2, Deise Terra Afonso3, Lisia Hoppe3,4, Ademir Orsolin5, Ana Paula Pompeo Vartha1.   

Abstract

INTRODUCTION: Health care professionals are vulnerable to several health problems, including overweight, stress and anxiety. As such, non-alcoholic fatty liver disease is a likely diagnosis in this population.
OBJECTIVES: To investigate the association between non-alcoholic fatty liver disease and levels of stress and anxiety in a sample of health care workers in a community hospital in the state of Rio Grande do Sul.
METHODS: The sample consisted of 107 health care workers who were interviewed and screened for non-alcoholic fatty liver disease based on clinical, imaging and laboratory parameters. Occupational stress was evaluated using Lipp's Stress Symptom Inventory, and anxiety was assessed using the Hamilton Anxiety Rating Scale.
RESULTS: The mean age of the sample was 37.6 years. Most participants were female (89.1%) and the most frequent occupation was nursing technicians (83.2%). While 77.22% of participants did not report significant levels of stress, 30.7% did have mild anxiety. Statistical tests did not reveal a significant association between non-alcoholic fatty liver disease and stress (p = 0.688) or anxiety (p = 0.996).
CONCLUSIONS: All participants with non-alcoholic fatty liver disease had some degree of anxiety, but only some experienced stress symptoms, according to Lipp's Inventory. Statistical tests did not confirm an association between stress, anxiety and the presence non-alcoholic fatty liver disease. Nevertheless, the potential association between these variables should continue to be investigated given the global rise in the prevalence of non-alcoholic fatty liver disease and its implications for health care workers.

Entities:  

Keywords:  anxiety; health; non-alcoholic fatty liver disease; professionals; stress

Year:  2021        PMID: 33688327      PMCID: PMC7934177          DOI: 10.47626/1679-4435-2020-582

Source DB:  PubMed          Journal:  Rev Bras Med Trab        ISSN: 1679-4435


  6 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

2.  Hamilton Rating Scale for Anxiety (HAM-A).

Authors:  Euan Thompson
Journal:  Occup Med (Lond)       Date:  2015-10       Impact factor: 1.611

3.  Work ability in nursing: relationship with psychological demands and control over the work.

Authors:  Andrea Prochnow; Tânia Solange Bosi de Souza Magnago; Janete de Souza Urbanetto; Carmem Lúcia Colomé Beck; Suzinara Beatriz Soares de Lima; Patrícia Bitencourt Toscani Greco
Journal:  Rev Lat Am Enfermagem       Date:  2013 Nov-Dec

4.  [Anxiety generating situations among nurses and strategies to control it: preliminary study].

Authors:  Alba Lucia Botura Leite de Barros; Dorisdaia Carvalho de Humerez; Flávio Trevisani Fakih; Jeanne Liliane Marlene Michel
Journal:  Rev Lat Am Enfermagem       Date:  2004-02-13

5.  Prevalence of obesity among U.S. workers and associations with occupational factors.

Authors:  Sara E Luckhaupt; Martha A Cohen; Jia Li; Geoffrey M Calvert
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

Review 6.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.